JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

Strona główna・Stock List・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Closed

6.59 3.62

Buy Sell

Overview

Share price change

24h

Current

Min

6.28

Max

6.65

Key metrics
By Trading Economics
Income	-1.5M -17M
Sales	-5.2M 47M
Profit margin	-36.715
Employees	477
EBITDA	-1.4M -14M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+31.77% upside

Dividends
By Dow Jones
Next Earnings	6 lis 2025

Market Stats
By TradingEconomics
Market Cap	80M 433M
Previous open	2.97
Previous close	6.59

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

7.16 / 7.65 Support & Resistance

Treace Medical Concepts Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

3 lis 2025, 21:44 UTC

Earnings

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3 lis 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3 lis 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3 lis 2025, 23:28 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3 lis 2025, 23:24 UTC

Earnings

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 lis 2025, 23:14 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

3 lis 2025, 23:14 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3 lis 2025, 23:12 UTC

Earnings

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3 lis 2025, 23:06 UTC

Market Talk

Earnings

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3 lis 2025, 22:36 UTC

Market Talk

Earnings

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3 lis 2025, 22:31 UTC

Earnings

Franco-Nevada 3Q EPS $1.49 >FNV

3 lis 2025, 22:31 UTC

Earnings

Franco-Nevada 3Q Rev $487.7M >FNV

3 lis 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3 lis 2025, 22:19 UTC

Acquisitions, Mergers, Takeovers

Starbucks Agrees to Sell Stake in China Business -- WSJ

3 lis 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3 lis 2025, 21:54 UTC

Market Talk

Earnings

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3 lis 2025, 21:54 UTC

Market Talk

Earnings

Global Equities Roundup: Market Talk

3 lis 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 lis 2025, 21:49 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3 lis 2025, 21:40 UTC

Earnings

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3 lis 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3 lis 2025, 21:19 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3 lis 2025, 21:11 UTC

Acquisitions, Mergers, Takeovers

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3 lis 2025, 21:11 UTC

Earnings

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3 lis 2025, 21:07 UTC

Earnings

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3 lis 2025, 21:05 UTC

Earnings

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3 lis 2025, 21:05 UTC

Earnings

Palantir Technologies 3Q Net $475.6M >PLTR

Peer Comparison

Price change

Treace Medical Concepts Inc Forecast

Price Target

By TipRanks

31.77% upside

12 Months Forecast

Average 8.42 USD 31.77%

High 12 USD

Low 6 USD

Based on 6 Wall Street analysts offering 12 month price targets forTreace Medical Concepts Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Treace Medical Concepts Inc - Dist in the past 3 months.

Technical Score

By Trading Central

7.16 / 7.65Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.